These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27216574)

  • 1. Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studies.
    Li Y; Monine M; Huang Y; Swann P; Nestorov I; Lyubarskaya Y
    MAbs; 2016; 8(6):1079-87. PubMed ID: 27216574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing in vivo dynamics of multiple quality attributes from a therapeutic IgG4 monoclonal antibody circulating in cynomolgus monkey.
    Li Y; Huang Y; Ferrant J; Lyubarskaya Y; Zhang YE; Li SP; Wu SL
    MAbs; 2016 Jul; 8(5):961-8. PubMed ID: 27030286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.
    Xu W; Jimenez RB; Mowery R; Luo H; Cao M; Agarwal N; Ramos I; Wang X; Wang J
    MAbs; 2017 Oct; 9(7):1186-1196. PubMed ID: 28805536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation and modeling of post-translational modifications in a therapeutic monoclonal antibody from single- and multiple-dose monkey pharmacokinetic studies using mass spectrometry.
    Xu X; Huang Y; Pan H; Molden R; Qiu H; Daly TJ; Li N
    PLoS One; 2019; 14(10):e0223899. PubMed ID: 31618250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.
    Rogers RS; Nightlinger NS; Livingston B; Campbell P; Bailey R; Balland A
    MAbs; 2015; 7(5):881-90. PubMed ID: 26186204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
    Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
    MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of profiling post-translational modifications of a circulating antibody drug in human with different capture reagents.
    Zhang Y; Wu SL; Li Y
    Biologicals; 2017 Jan; 45():93-95. PubMed ID: 27776829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
    Kellie JF; Thomson AS; Chen S; Childs SL; Karlinsey MZ; Mai SH; White JR; Biddlecombe RA
    J Pharm Sci; 2019 Apr; 108(4):1415-1422. PubMed ID: 30465782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.
    Peng K; Xu K; Liu L; Hendricks R; Delarosa R; Erickson R; Budha N; Leabman M; Song A; Kaur S; Fischer SK
    MAbs; 2014; 6(6):1500-8. PubMed ID: 25484037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ID-MAM: A Validated Identity and Multi-Attribute Monitoring Method for Commercial Release and Stability Testing of a Bispecific Antibody.
    Evans AR; Hebert AS; Mulholland J; Lewis MJ; Hu P
    Anal Chem; 2021 Jul; 93(26):9166-9173. PubMed ID: 34161073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should charge variants of monoclonal antibody therapeutics be considered critical quality attributes?
    Singh SK; Narula G; Rathore AS
    Electrophoresis; 2016 Sep; 37(17-18):2338-46. PubMed ID: 27387433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
    Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
    MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-step affinity purification of enzyme biotherapeutics: a platform methodology for accelerated process development.
    Brower KP; Ryakala VK; Bird R; Godawat R; Riske FJ; Konstantinov K; Warikoo V; Gamble J
    Biotechnol Prog; 2014; 30(3):708-17. PubMed ID: 24449601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel development of chromatographic and mass-spectrometric methods for quantitative analysis of glycation on an IgG1 monoclonal antibody.
    Viski K; Gengeliczki Z; Lenkey K; Baranyáné Ganzler K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():198-204. PubMed ID: 27179993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studies.
    Zhang Q; Spellman DS; Song Y; Choi B; Hatcher NG; Tomazela D; Beaumont M; Tabrizifard M; Prabhavalkar D; Seghezzi W; Harrelson J; Bateman KP
    Anal Chem; 2014 Sep; 86(17):8776-84. PubMed ID: 25010922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Identification of Critical Quality Attributes (CQAs) for the Development of Antibody Drugs].
    Saitoh S
    Yakugaku Zasshi; 2018; 138(12):1475-1481. PubMed ID: 30504661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a rapid RP-UHPLC-MS method for analysis of modifications in therapeutic monoclonal antibodies.
    Zhang B; Jeong J; Burgess B; Jazayri M; Tang Y; Taylor Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():172-181. PubMed ID: 27233581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of Therapeutic Proteins: A Critical Quality Attribute.
    Delobel A
    Methods Mol Biol; 2021; 2271():1-21. PubMed ID: 33907996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control.
    Yang F; Zhang J; Buettner A; Vosika E; Sadek M; Hao Z; Reusch D; Koenig M; Chan W; Bathke A; Pallat H; Lundin V; Kepert JF; Bulau P; Deperalta G; Yu C; Beardsley R; Camilli T; Harris R; Stults J
    MAbs; 2023; 15(1):2197668. PubMed ID: 37057828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.